Delivery Order SPE2DB22D1002-SPE2DB24FLFB4

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,499.68 firm-fixed-price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pens. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,738.96 firm fixed-price delivery order is for the supply of Wegovy 1 mg/0.5 ml pens, with an ultimate completion date of October 18, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Wegovy 0.5 mg/0.5 ml pens. The contract, valued at $9,094.03, is a firm fixed-price delivery order with an ultimate completion date of April 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Wegovy 0.25 mg/0.5 ml pens with a ceiling value of $11,306.40. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.92 firm-fixed-price delivery order is for the supply of Wegovy 1.7 mg/0.75 ml pens with a completion date of September 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,166.56 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Wegovy 0.25 mg/0.5 mL pens to support military treatment programs and facilities worldwide. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which enables the government to...
This delivery order for $1,049.90 was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the drug Wegovy 1.7 mg/0.75 ml pens. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Wegovy 0.5 mg/0.5 ml pens. The $2,194.16 firm fixed-price delivery order has a completion date of June 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,163.99, is for the delivery of Wegovy 0.25 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a final completion date of February 10, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Wegovy 1.7 mg/0.75 ml pens. The $1,645.62 order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLFB4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Wegovy 0.25 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,645.62, was issued as a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by July 19, 2024.

Generated 10/17/24, 9:37 AM